Northpointe Capital’s Globus Medical GMED Stock Holding History

Northpointe Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-72,017	Closed	-$3.12M	–	117
2018 Q4	$3.12M	Sell	72,017 -1,532	-2%	-$76.4K	0.7%	48
2018 Q3	$4.17M	Sell	73,549 -769	-1%	-$40.5K	0.6%	68
2018 Q2	$3.75M	Buy	+74,318	New	+$3.88M	0.5%	85
2014 Q3	–	Sell	-86,655	Closed	-$2.07M	–	251
2014 Q2	$2.07M	Sell	86,655 -227,200	-72%	-$5.48M	0.2%	144
2014 Q1	$8.35M	Sell	313,855 -319,203	-50%	-$7.59M	0.85%	46
2013 Q4	$12.8M	Buy	633,058 +342,935	+118%	+$6.37M	1.13%	22
2013 Q3	$5.07M	Sell	290,123 -14,480	-5%	-$251K	0.59%	54
2013 Q2	$5.14M	Buy	+304,603	New	+$4.7M	0.59%	57

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Northpointe Capital's GMED Position: Q1 2019 in Review

Northpointe Capital sold out of Globus Medical (GMED) in Q1 2019, closing a stake of 72,017 shares — an estimated $3.12M sold.

Northpointe Capital first reported a position in GMED in Q2 2013 and held it in 8 quarters. The position peaked at $12.8M in Q4 2013. 269 funds tracked by Wall St. Rank hold GMED as of Q1 2019.

Northpointe Capital reported no remaining Globus Medical position as of Q1 2019 after selling out during the quarter.
Northpointe Capital sold 72,017 Globus Medical shares in Q1 2019, an estimated $3.12M.
Northpointe Capital first reported a position in Globus Medical in Q2 2013 and held it in 8 quarters.
Northpointe Capital's Globus Medical position peaked at $12.8M in Q4 2013.
269 funds tracked by Wall St. Rank held Globus Medical as of Q1 2019.

Based on Northpointe Capital's 13F filing for Q1 2019, filed 17 Apr 2019.